Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :26176610
Publication Date : //

Functional and splicing defect analysis of 23 ACVRL1 mutations in a cohort of patients affected by Hereditary Hemorrhagic Telangiectasia.


Hereditary Hemorrhagic Telangiectasia syndrome (HHT) or Rendu-Osler-Weber (ROW) syndrome is an autosomal dominant vascular disorder. Two most common forms of HHT, HHT1 and HHT2, have been linked to mutations in the endoglin (ENG) and activin receptor-like kinase 1 (ACVRL1or ALK1) genes respectively. This work was designed to examine the pathogenicity of 23 nucleotide variations in ACVRL1 gene detected in more than 400 patients. Among them, 14 missense mutations and one intronic variant were novels, and 8 missense mutations were previously identified with questionable implication in HHT2. The functionality of missense mutations was analyzed in response to BMP9 (specific ligand of ALK1), the maturation of the protein products and their localization were analyzed by western blot and fluorescence microscopy. The splicing impairment of the intronic and of two missense mutations was examined by minigene assay. Functional analysis showed that 18 out of 22 missense mutations were defective. Splicing analysis revealed that one missense mutation (c.733A>G, p.Ile245Val) affects the splicing of the harboring exon 6. Similarly, the intronic mutation outside the consensus splicing sites (c.1048+5G>A in intron 7) was seen pathogenic by splicing study. Both mutations induce a frame shift creating a premature stop codon likely resulting in mRNA degradation by NMD surveillance mechanism. Our results confirm the haploinsufficiency model proposed for HHT2. The affected allele of ACVRL1 induces mRNA degradation or the synthesis of a protein lacking the receptor activity. Furthermore, our data demonstrate that functional and splicing analyses together, represent two robust diagnostic tools to be used by geneticists confronted with novel or conflicted ACVRL1 mutations.

Authors : Alaa El Din Ferdos , Patri Sylvie , Thoreau Vincent , Rodriguez-Ballesteros Montserrat , Hamade Eva , Bailly Sabine , Gilbert-Dussardier Brigitte , Abou Merhi Raghida , Kitzis Alain ,

Related products :

Catalog number Product name Quantity
orb61216 AZD6244 Activating mutations in the BRAF gene, primarily at V600E, are associated with poorer outcomes in patients with papillary thyroid cancer. For research use only. 500 mg
29-347 ZRSR2 is an essential splicing factor. The protein associates with the U2 auxiliary factor heterodimer, which is required for the recognition of a functional 3' splice site in pre-mRNA splicing, and m 0.1 mg
29-978 Alzheimer's disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1 or PSEN2) or the amyloid precursor protein (APP). These disease-linked mutatio 0.05 mg
29-791 Mutations in GNAS gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progr 0.1 mg
29-639 Mutations in GNAS gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progr 0.1 mg
25-797 Mutations in GNAS gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progr 0.05 mg
28-226 Mutations in nAChRs are found in a rare form of nocturnal frontal lobe epilepsy . Previously, some nAChR mutations have been described that are associated with additional neurological features such as 0.1 mg
28-714 Mutations in nAChRs are found in a rare form of nocturnal frontal lobe epilepsy . Previously, some nAChR mutations have been described that are associated with additional neurological features such as 0.1 mg
28-738 ZNF265 is a protein that has been shown to bind to the spliceosomal components U1-70K and U2AF35 and to direct alternative splicing. Analysis of the structure reveals substantial similarity to known R 0.1 mg
PR-727 PC4_mt (serine mutations) Positive Cofactor 4, serine mutations, Transcriptional Coactivator human, recombinant, E. coli 10µg
PR-727 PC4_mt (serine mutations) Positive Cofactor 4, serine mutations, Transcriptional Coactivator human, recombinant, E. coli 10 µg
PR-727 PC4-mt (serine mutations) Positive Cofactor 4, serine mutations, Transcriptional Coactivator human, recombinant, E. coli 10
PR-727 Proteins: PC4-mt (serine mutations) Positive Cofactor 4, serine mutations, Transcriptional Coactivatorhuman, recombinant, E. coli 10
PR-727 PC4-mt (serine mutations) Positive Cofactor 4, serine mutations, Transcriptional Coactivatorhuman, recombinant, E. coli 10
EIAAB39962 Alternative-splicing factor 1,ASF,ASF-1,Homo sapiens,Human,OK_SW-cl.3,pre-mRNA-splicing factor SF2, P33 subunit,Serine_arginine-rich splicing factor 1,SF2,SF2P33,SFRS1,Splicing factor, arginine_serine
EIAAB39964 Mouse,MRF-1,Mus musculus,Pr264,Protein PR264,Putative myelin regulatory factor 1,SC-35,Serine_arginine-rich splicing factor 2,Sfrs10,Sfrs2,Splicing component, 35 kDa,Splicing factor SC35,Splicing fact
EIAAB39967 Homo sapiens,Human,Protein PR264,SC-35,Serine_arginine-rich splicing factor 2,SFRS2,Splicing component, 35 kDa,Splicing factor SC35,Splicing factor, arginine_serine-rich 2,SRSF2
29-368 SFRS6 is involved in mRNA splicing and may play a role in the determination of alternative splicing. It belongs to the splicing factor SR family and has been shown to bind with and modulate another me 0.05 mg
EIAAB39965 Rat,Rattus norvegicus,SC-35,Serine_arginine-rich splicing factor 2,Sfrs2,Splicing component, 35 kDa,Splicing factor SC35,Splicing factor, arginine_serine-rich 2,Srsf2
EIAAB39968 Bos taurus,Bovine,SC-35,Serine_arginine-rich splicing factor 2,SFRS2,Splicing component, 35 kDa,Splicing factor SC35,Splicing factor, arginine_serine-rich 2,SRSF2
EIAAB39963 Pig,SC-35,Serine_arginine-rich splicing factor 2,SFRS2,Splicing component, 35 kDa,Splicing factor SC35,Splicing factor, arginine_serine-rich 2,SRSF2,Sus scrofa
20-372-60158 ataxia telangiectasia mutated (includes complementation groups A. C and D) (ATM). transcript variant 1 - Mouse monoclonal anti-human ATM antibody; EC 2.7.11.1; Ataxia telangiectasia mutated; A-T. muta 0.1 mg
EIAAB39966 Chicken,Gallus gallus,Protein PR264,SC-35,Serine_arginine-rich splicing factor 2,SFRS2,Splicing component, 35 kDa,Splicing factor SC35,Splicing factor, arginine_serine-rich 2,SRSF2
ACVRL1-768H Recombinant Human ACVRL1 activin A receptor type II-like 1, FC-tagged species: Human 200
LF-PA43802 Anti-ACVRL1, Rabbit Polyclonal to ACVRL1, Isotype IgG, Host Rabbit 50


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur